arrow_back Back Filing freshness 10-K FY 2026 SEC EDGAR

PETMED EXPRESS INC

PETS
$1.99 ▲ +0.02 (+1.02%) at close
Healthcare ·Retail-Drug Stores and Proprietary Stores ·USRetail-Drug Stores and Proprietary Stores
18 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
9
Health
Poor
Bearish
auto_awesome

Analytical Summary

PETMED EXPRESS INC faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $41.6M
Dividend Yield
Revenue Growth -21.1%
Op. Margin -32.8%
ROIC -202.5%
FCF / Share $-1.58
Trailing P/E
Price / Book 1.5x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$179.02M
↓ -21.1%
Net Income Profit after all expenses
$-57.29M
↓ -813.5%
Operating Margin Operating profit as % of sales
-32.8%
↓ -4762.0% 2th
FCF / Share Free cash flow per share
$-1.58
↓ -8126.8%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
4
Returns
2
Cash Quality
39

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 66 quarters